HIF pathway activation is a core regulator of collagen structure-function in lung fibrosis
HIF pathway activation is a core regulator of collagen structure-function in lung fibrosis
Background: altered collagen architecture with increased “bone-type” pyridinoline collagen cross-linking, rather than collagen quantity, is a key determinant of abnormal tissue structure-function in Idiopathic Pulmonary Fibrosis (IPF). We recently identified that hypoxia inducible factor (HIF) pathway activation promotes induction of the bone-type collagen cross-linking enzymes lysyl hydroxylase 2 and lysyl oxidase-like 2, yet the consequences of this on collagen structure-function in lung fibrosis remain unknown.
Methods: using a long term 3D in vitro model of the fibroblastic focus we cultured primary lung fibroblasts from IPF donors without or with the HIF-stabilising compound IOX2. Hydroxyproline and mature pyridinium cross-links were measured by colorimetric assays, and collagen ultrastructure assessed by electron microscopy (EM). The biomechanical effects of HIF stabilisation were investigated by parallel plate compression testing.
Results: IOX2 stabilised HIF within the 3D fibroblastic focus model, promoting HIF pathway activation to disproportionately induce collagen-modifying enzymes relative to collagen fibril synthesis. After 6 weeks of culture, mature pyridinium cross-links were significantly increased by IOX2 to levels we have previously observed in IPF tissue. Ultrastructural analysis of the collagen fibrils with EM identified that IOX2 significantly reduced fibril diameter to sizes comparable with collagen fibrils enzymatically extracted from IPF tissue. IOX2 induced a greater than 3-fold increase in tissue stiffness.
Conclusions: HIF pathway activation is a core regulator of bone-type collagen fibrillogenesis and altered structure-function in lung fibrosis.
Brereton, Christopher J.
14b6396e-9e2c-4313-b337-71df6e0d8c8d
Ridley, Robert
1a08f6e6-990e-4703-a740-e0920ba93eec
Conforti, Franco
1a56ef07-690f-46c2-8c4c-9b98cea576f6
Yao, Liudi
4cf26f9c-c687-4b50-993f-6908a205aca4
Alzetani, Aiman
04d65796-5c8e-4c5b-aeeb-ea093c118f03
Marshall, Ben
a5cf0614-864b-4a1e-9148-e8c13e288e72
Fletcher, Sophie V.
71599088-9df7-4d4a-8570-aef773ead0fe
Richeldi, Luca
89f3b3b9-2dc9-4803-a190-3d4facabd8c2
Wang, Yihua
dac745a1-b864-422d-9c30-fd92fbc9c21b
Davies, Donna E.
7d0beb15-015d-49f2-a2af-8763f5d66e31
Jones, Mark G.
119d23fa-c777-482a-8eb4-69d3bd499791
28 October 2020
Brereton, Christopher J.
14b6396e-9e2c-4313-b337-71df6e0d8c8d
Ridley, Robert
1a08f6e6-990e-4703-a740-e0920ba93eec
Conforti, Franco
1a56ef07-690f-46c2-8c4c-9b98cea576f6
Yao, Liudi
4cf26f9c-c687-4b50-993f-6908a205aca4
Alzetani, Aiman
04d65796-5c8e-4c5b-aeeb-ea093c118f03
Marshall, Ben
a5cf0614-864b-4a1e-9148-e8c13e288e72
Fletcher, Sophie V.
71599088-9df7-4d4a-8570-aef773ead0fe
Richeldi, Luca
89f3b3b9-2dc9-4803-a190-3d4facabd8c2
Wang, Yihua
dac745a1-b864-422d-9c30-fd92fbc9c21b
Davies, Donna E.
7d0beb15-015d-49f2-a2af-8763f5d66e31
Jones, Mark G.
119d23fa-c777-482a-8eb4-69d3bd499791
Brereton, Christopher J., Ridley, Robert, Conforti, Franco, Yao, Liudi, Alzetani, Aiman, Marshall, Ben, Fletcher, Sophie V., Richeldi, Luca, Wang, Yihua, Davies, Donna E. and Jones, Mark G.
(2020)
HIF pathway activation is a core regulator of collagen structure-function in lung fibrosis.
European Respiratory Journal, 56 (Suppl 64), [4323].
(doi:10.1183/13993003.congress-2020.4323).
Record type:
Meeting abstract
Abstract
Background: altered collagen architecture with increased “bone-type” pyridinoline collagen cross-linking, rather than collagen quantity, is a key determinant of abnormal tissue structure-function in Idiopathic Pulmonary Fibrosis (IPF). We recently identified that hypoxia inducible factor (HIF) pathway activation promotes induction of the bone-type collagen cross-linking enzymes lysyl hydroxylase 2 and lysyl oxidase-like 2, yet the consequences of this on collagen structure-function in lung fibrosis remain unknown.
Methods: using a long term 3D in vitro model of the fibroblastic focus we cultured primary lung fibroblasts from IPF donors without or with the HIF-stabilising compound IOX2. Hydroxyproline and mature pyridinium cross-links were measured by colorimetric assays, and collagen ultrastructure assessed by electron microscopy (EM). The biomechanical effects of HIF stabilisation were investigated by parallel plate compression testing.
Results: IOX2 stabilised HIF within the 3D fibroblastic focus model, promoting HIF pathway activation to disproportionately induce collagen-modifying enzymes relative to collagen fibril synthesis. After 6 weeks of culture, mature pyridinium cross-links were significantly increased by IOX2 to levels we have previously observed in IPF tissue. Ultrastructural analysis of the collagen fibrils with EM identified that IOX2 significantly reduced fibril diameter to sizes comparable with collagen fibrils enzymatically extracted from IPF tissue. IOX2 induced a greater than 3-fold increase in tissue stiffness.
Conclusions: HIF pathway activation is a core regulator of bone-type collagen fibrillogenesis and altered structure-function in lung fibrosis.
This record has no associated files available for download.
More information
Published date: 28 October 2020
Identifiers
Local EPrints ID: 486028
URI: http://eprints.soton.ac.uk/id/eprint/486028
ISSN: 0903-1936
PURE UUID: ca37a8ce-1b4f-4351-9620-626bfadefc58
Catalogue record
Date deposited: 05 Jan 2024 18:06
Last modified: 21 Sep 2024 02:15
Export record
Altmetrics
Contributors
Author:
Christopher J. Brereton
Author:
Robert Ridley
Author:
Franco Conforti
Author:
Liudi Yao
Author:
Aiman Alzetani
Author:
Ben Marshall
Author:
Sophie V. Fletcher
Author:
Luca Richeldi
Author:
Yihua Wang
Author:
Donna E. Davies
Author:
Mark G. Jones
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics